Unity Biotechnology, Inc. (UBX) Insider Trading & SEC Filings
Last SEC filing
Unity Biotechnology, Inc. (UBX) - no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every UBX SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About Unity Biotechnology, Inc. (UBX)
Unity Biotechnology, Inc. trades under the ticker UBX. InsiderAlpha tracks 3 primary SEC Form 4 filings from 3 reporting insiders for UBX since 2024, sourced directly from SEC EDGAR.
| SEC CIK | 0001463361 |
|---|
Recent UBX Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Alexander Hieu Nguyen | Chief Legal Officer | S - Open-market sale [10b5-1] | 149 | $1.29 | $192 | SEC | |
| Lynne Marie Sullivan | CFO & Head of Corp. Dev. | S - Open-market sale [10b5-1] | 136 | $1.29 | $175 | SEC | |
| Anirvan Ghosh | Chief Executive Officer | S - Open-market sale [10b5-1] | 432 | $1.29 | $557 | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Unity Biotechnology, Inc. (UBX). Updated in real time as new filings are submitted to the SEC.
Recent Insider Filings
- - Alexander Hieu Nguyen (Chief Legal Officer)
- - Lynne Marie Sullivan (CFO & Head of Corp. Dev.)
- - Anirvan Ghosh (Chief Executive Officer)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in UBX insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
UBX Insider Trading - FAQ
- What is the latest insider trade for UBX?
- Unity Biotechnology, Inc. (UBX) had 0 insider filings in the last 90 days, with the most recent on 2024-11-06. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying UBX stock?
- 0 insider purchases of UBX were filed in the last 90 days.
- How many insiders are selling UBX stock?
- 0 insider sales of UBX were filed in the last 90 days.
- Where can I see UBX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks UBX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $UCAR U Power Ltd
- $UEEC United Health Products, Inc.
- $UHP Ultra High Point Holdings Ltd
- $UOKAF MDJM LTD
- $UPB Upstream Bio, Inc.
- $UPX Uptrend Holdings Ltd
- $UPXI UPEXI, INC.
- $URGO urban-gro, Inc.
- $URSB URSB Bancorp, Inc.
- $UZX Linkage Global Inc
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live UBX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.